Natera Inc at Canaccord Genuity Growth Conference (Virtual) Transcript
Hi. Welcome to the 41st Annual Canaccord Genuity Global Growth Conference. I'm Kyle Mikson, from Life Science Tools & Diagnostics at Canaccord. And we're pleased to have Natera here with us today. Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of company is to change the management of disease worldwide with focus on women's health, oncology and organ health. Representing the company, we have Mike Brophy, CFO. Great to have you here, Mike. Thanks for joining us today.
Thanks for having me, Kyle. Great to be here.
Questions & Answers
Sure. So Mike, just set the stage. So let's start with the 2Q results. So Natera announced last week results ahead of your preliminary numbers announced July 19, and you increased your revenue guidance to $620 million, which is impressive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |